TOTAL BOYS GIRLS 12-15 YRS 16-19 YRS
NATIONAL NEWS 66 66 66 60 71
LOCAL NEWS 60 59 61 56 63
SPORTS 56 69 41 55 58
INTERNATIONAL NEWS 36 38 32 32 39
NEWS ON BOLLYWOOD/HOLLYWOOD 32 30 35 28 36
EDUCATION SUPPLEMENTS 29 26 32 25 32
CARTOON STRIPS 26 25 28 34 19
CHILDREN’S SECTION 23 21 27 30 18
ADVERTISEMENTS 22 22 22 20 24
YOUTH SUPPLEMENTS 17 15 19 12 21
Thursday, September 23, 2010
Monday, September 13, 2010
ORGANIZED RETAIL PENETRATION
FOOTWARE: 38.4%
EQUIPMENT,PAPER,AND STATIONERY: 29.7%
HOUSEHOLD APPLIANCES: 24.6%
CLOTHING AND TEXTILE: 21.7%
COMMUNICATION: 11.4%
HOME DECOR AND FURNISHING: 5.0%
BEAUTY,PERSONAL AND HEALTH CARE: 4.9%
EQUIPMENT,PAPER,AND STATIONERY: 29.7%
HOUSEHOLD APPLIANCES: 24.6%
CLOTHING AND TEXTILE: 21.7%
COMMUNICATION: 11.4%
HOME DECOR AND FURNISHING: 5.0%
BEAUTY,PERSONAL AND HEALTH CARE: 4.9%
Friday, September 10, 2010
Share of wallet in India Shifting from food to more Discretionary Spending
(In percentages)
Spendings 1995 2005 2015E 2025E
Health Care 4,7,9,13
Education and recreation 3,5,6,9
communication 1,2,3,6
Transportation 11,17,19,20
Personal products and services 4,8,9,11
Household products 2,3,3,3
Housing and utilities 14,12,12,10
Apparel 5,6,5,5
Food,beverages and tobacco 56,42,34,25
(E means estimated)
Spendings 1995 2005 2015E 2025E
Health Care 4,7,9,13
Education and recreation 3,5,6,9
communication 1,2,3,6
Transportation 11,17,19,20
Personal products and services 4,8,9,11
Household products 2,3,3,3
Housing and utilities 14,12,12,10
Apparel 5,6,5,5
Food,beverages and tobacco 56,42,34,25
(E means estimated)
Monday, September 6, 2010
Favourite TV Channels Zone -Wise(%)
Favourite TV Channels Zone -Wise(%)
North South West East
Star Plus 38 SUN TV 28 Star Plus 24 Star Plus 23
Colors 30 Vijaya TV 20 Colors 14 Zee TV 19
Zee TV 19 SUN Music 11 Sony TV 14 Colors 13
North South West East
Star Plus 38 SUN TV 28 Star Plus 24 Star Plus 23
Colors 30 Vijaya TV 20 Colors 14 Zee TV 19
Zee TV 19 SUN Music 11 Sony TV 14 Colors 13
DEFINITION OF A MOPED
In most countries, the legal driving age for a moped is lower than for regular motorcycles and cars. Mopeds are typically restricted to 50 km/h (30 mph) from a maximum engine displacement of 49 cc (3.0 cu in), though there are a few variations.
Percentage share of each sub segment within Two Wheelers in India
Electric Vehicle: 0.3%
Moped : 5.7%
Scooters : 15.6%
Motor Cycles : 78.3%
Moped : 5.7%
Scooters : 15.6%
Motor Cycles : 78.3%
Saturday, September 4, 2010
MIS: SIZE OF MINERAL WATER IN INDIA
the organized mineral water market is estimated to be about Rs 3,000 crore.this is exclusive of filters installed at homes. The total mineral water market is rs 10000 crores
MIS: SIZE OF MINERAL WATER IN INDIA
the organized mineral water market is estimated to be about Rs 3,000 crore.this is exclusive of filters installed at homes. The total mineral water market is rs 10000 crores
PHARMA INDUSTRY
As promised daily I will be providing some data for you to analyze on this blog.
The global pharma industry is around 800 billion USD, whereas Indian pharma industry is only 8 billion USD. However contrast to it is Indian Pharma Industry is growing annually at 10% whereas Global Pharma Industry is growing at 7%.
Indian pharma companies are doing good in generic area. The acquisition of Piramal Healthcare’s domestic formulations business by American pharma major Abbott Laboratories has altered the landscape of the Indian pharmaceutical market in more ways than one. Not only has it taken Abbott to the top of the table with a market share of 7%—way ahead of current market leader Cipla—it also heralds the dominance of the domestic pharma market by multinationals. Three of the top five companies in terms of market share are now multinationals. This includes Abbott, Ranbaxy (now a Daiichi-Sankyo company) and GlaxoSmithKline. With a market share of 4.9%, Ranbaxy is in the third spot followed by GSK at 4.3%.
Cipla (5.4% market share) and Zydus Cadila (3.7% market share) are now the only two Indian firms in the top five. Compare this to 2007, when only two pharma MNCs figured in the top 10 list. According to pharma industry analysts, the share of MNCs in the Rs 40,051 crore Indian pharmaceutical market will continue to rise from the current 25%.The Abbott deal—it includes a $2.12 billion upfront payment and an additional $400 million paid annually for four years—is a shot in the arm for the American pharma major. Not only does it expand Abbott’s India portfolio, it also significantly enhances its sales network. While Abbott India’s portfolio includes drugs in areas like gastroenterology, urology, pain and metabolic disorders, the acquired business consists of antibiotics, respiratory drugs and cardiovascular products. Abbott India employs 2,500 people. It will now have an additional workforce of 5,000 from the acquired Piramal unit.
The global pharma industry is around 800 billion USD, whereas Indian pharma industry is only 8 billion USD. However contrast to it is Indian Pharma Industry is growing annually at 10% whereas Global Pharma Industry is growing at 7%.
Indian pharma companies are doing good in generic area. The acquisition of Piramal Healthcare’s domestic formulations business by American pharma major Abbott Laboratories has altered the landscape of the Indian pharmaceutical market in more ways than one. Not only has it taken Abbott to the top of the table with a market share of 7%—way ahead of current market leader Cipla—it also heralds the dominance of the domestic pharma market by multinationals. Three of the top five companies in terms of market share are now multinationals. This includes Abbott, Ranbaxy (now a Daiichi-Sankyo company) and GlaxoSmithKline. With a market share of 4.9%, Ranbaxy is in the third spot followed by GSK at 4.3%.
Cipla (5.4% market share) and Zydus Cadila (3.7% market share) are now the only two Indian firms in the top five. Compare this to 2007, when only two pharma MNCs figured in the top 10 list. According to pharma industry analysts, the share of MNCs in the Rs 40,051 crore Indian pharmaceutical market will continue to rise from the current 25%.The Abbott deal—it includes a $2.12 billion upfront payment and an additional $400 million paid annually for four years—is a shot in the arm for the American pharma major. Not only does it expand Abbott’s India portfolio, it also significantly enhances its sales network. While Abbott India’s portfolio includes drugs in areas like gastroenterology, urology, pain and metabolic disorders, the acquired business consists of antibiotics, respiratory drugs and cardiovascular products. Abbott India employs 2,500 people. It will now have an additional workforce of 5,000 from the acquired Piramal unit.
Few important M & A of recent times in pharma industry in India are :
Sr. No. | Company (Acquirer) | Company (Target) | For Amount | Segment Involved |
1. | Biocon | Axicorp (German) | $ 30 million | Biosimilars |
2. | Dr. Reddy’s Labs | Trigenesis Therapeutics (USA) | $ 11 million | Speciality Drugs |
3. | Wockhardt | Esparma (German) | $ 11 million | Branded Generics |
4. | Wockhardt | C. P. Pharmaceuticals (UK) | Rs. 83 crore | Healthcare Products |
5. | Wockhardt | Negma Laboratories (France) | $ 265 million | R&D |
6. | Wockhardt | Morton Grove Pharma (USA) | $38 million | Liquid Generics |
7. | Zydus Cadilla | Alpharma (France) | 5.5 million Euros | Formulation Business |
8. | Ranbaxy | RPG Aventis (France) | $ 70 million | Generic Drugs |
9. | Nicholas Piramal | Biosyntech (Canada) | $4.85mn | Regenerative-Heel Pain |
Other major global takeovers in the pharmaceutical sector are shown in the following table:
Sr. No. | Company (Acquirer) | Company (Target) | For Amount | Segment Involved |
1. | Roche (Swiss) | Genentech (USA) | $46.8bn | R&D, Cancer Drugs |
2. | Daiichi Sankyo (Japan) | Ranbaxy (India) | $4.2bn | Generic Drugs |
3. | Fresenius Kabi (German) | Dabur Pharma (India) | Rs.1000 Cr. | Oncology |
4. | Abbot (USA) | Wockhardt (India) | $22.5mn | Nutrition |
5. | Merck (USA) | Schering Plough (USA) | $41.1bn | Cardiovascular Meds |
Friday, September 3, 2010
SIZE OF MINERAL WATER IN INDIA
The total organized bottled water market is estimated to be about Rs 3,000 crore and is growing at 30% annually. Bisleri has a 60% market share . it's a Rs 10,000 crore market includinjavascript:void(0)g the unorganized sector.
Read the details in The Economic Times today on the front page "Bisleri ......"
Read the details in The Economic Times today on the front page "Bisleri ......"
Thursday, September 2, 2010
IMPORTANT DATA FOR ANALYSIS
Category penetration in India
All India % Urban% Rural %
Toilet Soaps 91.5 97.4 88.9
Detergent bar 88.6 91.4 87.4
Washing powder 86.1 90.7 84.1
Toothpaste 48.6 74.9 37.6
Shampoo 38 52.1 31.9
Utensil cleaner 28 59.9 14.6
Skin cream 22 31.5 17.8
Instant coffee 6.6 15.5 2.8
Deodorants 2.1 5.5 0.6
All India % Urban% Rural %
Toilet Soaps 91.5 97.4 88.9
Detergent bar 88.6 91.4 87.4
Washing powder 86.1 90.7 84.1
Toothpaste 48.6 74.9 37.6
Shampoo 38 52.1 31.9
Utensil cleaner 28 59.9 14.6
Skin cream 22 31.5 17.8
Instant coffee 6.6 15.5 2.8
Deodorants 2.1 5.5 0.6
Subscribe to:
Posts (Atom)